Clinical trials recruiting in Swidnica, Poland

Phase breakdown

Conditions recruiting in Swidnica, Poland

Recruiting trials in Swidnica, Poland

• A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
  NCT06671054 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
  NCT06833749 · Phase: Phase 2 · Ages: 45 Years and older · Sex: All (male and female)
• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
  NCT06456593 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
  NCT06641089 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
  NCT07580716 · Phase: Phase 2 · Ages: 64 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Swidnica, Poland?

5 recruiting trials have at least one study site in Swidnica, Poland.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.